Skip to content
cccskills
FreePublished on GitHub

es-cushing-discontinue-glucocorticoid-normal-hpa-response

This skill recommends discontinuing glucocorticoid when the response to HPA axis recovery tests (morning cortisol, ACTH stimulation, or insulin-induced hypoglycemia) is normal, indicating adequate adrenal function recovery. Use in postoperative Cushing’s syndrome patients with at least one intact adrenal gland when test results are available.

The English summary is being prepared. Showing the original description.

Run score Not tested

See how to install

Files included (1)

  • SKILL.md2.4 KB

SKILL.md (original)

Review the instructions the agent will receive before you install.

Discontinuing Glucocorticoid When HPA Axis Recovery Response Is Normal

STEP 1 — Gather Information

Confirm postoperative Cushing’s syndrome patient with at least one intact adrenal gland. Obtain morning serum cortisol, ACTH stimulation test (baseline and peak cortisol), or insulin-induced hypoglycemia test results.

STEP 2 — Rule In / Rule Out

Determine if HPA axis recovery is normal: morning cortisol ≥5 µg/dL (138 nmol/L) OR ACTH-stimulated cortisol ≥18 µg/dL (500 nmol/L) OR adequate cortisol rise during insulin-induced hypoglycemia (per local lab norms). If any test meets normal criteria, proceed; otherwise, HPA axis not recovered.

STEP 3 — Classify or Stratify

If normal response: classify as HPA axis recovered. If subnormal: classify as HPA axis insufficient, requiring continued glucocorticoid replacement.

STEP 4 — Decide

Discontinue glucocorticoid (e.g., taper hydrocortisone off) and provide patient education on adrenal insufficiency signs and stress dosing. If not normal, continue glucocorticoid and schedule repeat testing in 3–6 months.

Clinical Guardrails / Mimics / Pitfalls

Do not discontinue glucocorticoid if any test is subnormal; monitor for glucocorticoid withdrawal symptoms (fatigue, nausea, weight loss). Ensure patient knows stress-dosing for illness. Avoid mistaking withdrawal for recurrence; assess clinically and biochemically if symptoms persist.

Concrete Clinical Example

A 45‑year‑old woman 8 months after transsphenoidal resection of an ACTH‑secreting pituitary adenoma has morning cortisol 6.2 µg/dL and ACTH stimulation peak 22 µg/dL. Both exceed normal thresholds, so glucocorticoid is tapered and discontinued with instructions on stress dosing.

Source: Treatment of Cushing’s Syndrome: An Endocrine Society Clinical Practice Guideline, Nieman et al., 2015, DOI:10.1210/jc.2015-1818

TODO: consider adding scripts/calc.py for the es-cushing-discontinue-glucocorticoid-normal-hpa-response calculator

Reviews

No reviews yet. Tell others what you thought.

Comments

No login needed. Share how it worked for you, ask a question, or note where it did not run.

No comments yet. Be the first to write one.

Comments are published right away. Do not include personal information such as email addresses or phone numbers. Up to 2 URLs.

0 / 1,000 characters

This form is protected by reCAPTCHA, and the Google Privacy Policy and Terms of Service apply.

More skills from this repository

Guide pump setting adjustments for the MiniMed 780G system based on CareLink data, using Medtronic's 3-step follow-up workflow. Use when a clinician has CareLink data for a 780G patient and wants to know what to change — which setting, by how much, and how to program it. Triggers include: "what do I adjust", "how to fix high TIR", "how to reduce hypos", "adjust ICR/ISF/basal", "SmartGuard settings", "780G pump settings review", or any question about optimising 780G therapy after reviewing a download.

The English summary is being prepared. Showing the original description.

dromlakhani/MD2SKILL14Updated Oct 20, 2026

Performs corticotropin stimulation test to diagnose adrenal insufficiency when morning cortisol is indeterminate (3-15 µg/dL). Triggers include morning cortisol 3-15 µg/dL requiring further AI testing.

The English summary is being prepared. Showing the original description.

dromlakhani/MD2SKILL14Updated Oct 20, 2026

Administers immediate parenteral injection of 50–100 mg hydrocortisone for suspected adrenal crisis secondary to adrenal insufficiency. Triggers include hypotension, hypoglycemia, or acute illness in a patient with known adrenal insufficiency.

The English summary is being prepared. Showing the original description.

dromlakhani/MD2SKILL14Updated Oct 20, 2026

Clinicians educate adrenal insufficiency patients taking nondexamethasone glucocorticoids who initiate enzyme-inducing antiepileptic drugs about early signs of adrenal insufficiency. Trigger when an AI patient on nondexamethasone GC starts an enzyme-inducing AED such as phenytoin, carbamazepine, or oxcarbazepine.

The English summary is being prepared. Showing the original description.

dromlakhani/MD2SKILL14Updated Oct 20, 2026

In central hypothyroidism patients receiving levothyroxine who initiate enzyme‑inducing antiepileptic drugs, the guideline recommends checking free T4 at least 6 weeks after AED start and increasing the levothyroxine dose if free T4 falls below the target range. Triggers include: central hypothyroidism patient on levothyroxine starting antiepileptic drug such as phenytoin, carbamazepine, or oxcarbazepine.

The English summary is being prepared. Showing the original description.

dromlakhani/MD2SKILL14Updated Oct 20, 2026

Applies serum cortisol cutoffs (<3 μg/dL indicates central adrenal insufficiency; >15 μg/dL likely excludes it) when evaluating morning cortisol for suspected adrenal insufficiency. Triggers include morning cortisol measurement in suspected AI and use when interpreting morning cortisol levels for adrenal insufficiency workup.

The English summary is being prepared. Showing the original description.

dromlakhani/MD2SKILL14Updated Oct 20, 2026

See all skills by dromlakhani

Report a problem with this skill